BR Avalos
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- Neutropenia and Cancer Infections
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 1
- Oncology 5
- Cytokine Signaling Pathways and Interactions 3
- Neutropenia and Cancer Infections 3
- Co-authors
- EA Copelan (7 shared papers)Richard H. Weisbart (1 shared paper)David W. Golde (1 shared paper)JF DiPersio (1 shared paper)GC Baldwin (1 shared paper)JC Gasson (1 shared paper)Cyrus V. Hedvat (1 shared paper)Sam L. Penza (5 shared papers)
- Journals
- Blood (7 papers)Bone Marrow Transplantation (5 papers)Journal of Clinical Oncology (1 paper)PubMed (3 papers)
- Partner nations
- United States
In The Last Decade
BR Avalos
15 papers receiving 901 citations
Peers
Comparison fields: 5 of 60
- Hematology 341
- Oncology 268
- Immunology 114
- Statistics and Probability 60
- Pathology and Forensic Medicine 76
Countries citing papers authored by BR Avalos
This map shows the geographic impact of BR Avalos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BR Avalos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BR Avalos more than expected).
Fields of papers citing papers by BR Avalos
This network shows the impact of papers produced by BR Avalos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BR Avalos. The network helps show where BR Avalos may publish in the future.
Co-authors
The 25 scholars most cited alongside BR Avalos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 265 | |
| 2 | 1990 | 221 | |
| 3 | 1991 | 145 | |
| 4 | 2001 | 63 | |
| 5 | 2000 | 52 | |
| 6 | 1995 | 36 | |
| 7 | 1994 | 29 | |
| 8 | 1992 | 25 | |
| 9 | 2000 | 23 | |
| 10 | Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY. | 1993 | 21 |
| 11 | 1996 | 19 | |
| 12 | 2002 | 16 | |
| 13 | 1994 | 15 | |
| 14 | 2005 | 8 | |
| 15 | Second autologous bone marrow transplantation in Hodgkin's disease. | 1993 | 3 |
| 16 | Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide. | 1993 | 1 |
About BR Avalos
BR Avalos is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Genetics and Immunology, having authored 16 papers that have together received 942 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Neutropenia and Cancer Infections (3 papers), Blood disorders and treatments (3 papers), Transplantation: Methods and Outcomes (1 paper), Acute Myeloid Leukemia Research (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Hematology (341 citations), Oncology (268 citations), Immunology (114 citations), Statistics and Probability (60 citations) and Pathology and Forensic Medicine (76 citations). BR Avalos has collaborated with scholars based in United States. Frequent co-authors include EA Copelan, Richard H. Weisbart, David W. Golde, JF DiPersio, GC Baldwin, JC Gasson, Cyrus V. Hedvat, Sam L. Penza, Isabel B. Cunningham and Kerry Atkinson. Their work appears in journals such as Blood, Bone Marrow Transplantation, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.